Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm	Active, not recruiting	Phase 2 / Phase 3	2026-01-23		NCT04208347

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ruijin Hospital	454

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Hebei University	Baoding	China	8
Affiliated Hospital of Jiangsu University	Zhenjiang	China	2
Cancer Hospital Chinese Academy of Medical Sciences	Beijing	China	33
Cancer Hospital of The University of Chinese Academy of Sciences	Hangzhou	China	2
Changhai Hospital	Shanghai	China	21
First Affiliated Hospital of Xi'an Jiaotong University	Xi'an	China	3
Hainan Cancer Hospital	Haikou	China	2
Hefei Cancer Hospital, Chinese Academy of Sciences	Hefei	China	1
Henan Provincial Cancer Hospital	Zhengzhou	China	3
Heping Hospital Affiliated to Changzhi Medical College	Changzhi	China	5
Jilin Guowen Hospital	Siping	China	1
Lanzhou University Second Hospital	Lanzhou	China	4
Liaoning Cancer Hospita & Institute	Shenyang	China	1
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	21
Shanxi Provincial Cancer Hospital	Taiyuan	China	16
Sichuan Cancer Hospital & Institute	Chengdu	China	6
Sichuan Provincial People's Hospital	Chengdu	China	27
Tangdu Hospital	Xi'an	China	3
The Affiliated Hospital of Guizhou Medical University	Guiyang	China	8
The Fourth Hospital of Hebei Medical University	Shijiazhuang	China	16
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	18
Xiangya Hospital central south university	Changsha	China	12
Yantai YuHuangDing Hospital	Yantai	China	20

Clinical trials